In the human body, there are approximately 30,000 genes. At birth, a large number of genes are active, to promote growth and intellectual development. As we age, fewer and fewer of these genes are active, resulting in a slowdown in bodily functions, weakened immunity, reduced metabolism, loss of energy, baldness, and other typical signs of aging. This process involves silencing of genes through methylation of promoter sequences and deacetylation of histones. The end result is that good genes, which promote regeneration and general health, are "switched off" and bad genes, that encourage deterioration and disease, may be "switched on."

Studies at The Burzynski Clinic are indicating that some formulations have the ability to reverse and slow down the aging process. Peptides and amino acid derivatives, named antineoplastons, developed by Stanislaw R. Burzynski, M.D., Ph.D., are believed to work as molecular switches, turning on inactive tumor suppressor genes, as well as other genes silenced during the aging process. Components similar to these antineoplastons are the active ingredients found in Aminocare® products, which work genetically on the molecular level to reverse signs of aging.

Stanislaw R. Burzynski, M.D., Ph.D., internationally recognized physician and scientist, has been treating patients with terminal cancer for over 25 years. In May 1977 he founded the Burzynski Clinic in Houston. He also serves as director of the Burzynski Research Institute, where he continues to pursue scientific research on causes and treatments for cancer.

The Burzynski Clinic provides high quality, personalized cancer treatment for patients from all parts of the world. It offers a totally modern medical facility with a friendly and positive atmosphere. The clinic offers complete treatment for patients, including consultations.